Staphylococcal Enterotoxin C2 Mutant-Induced Antitumor Immune Response Is Controlled by CDC42/MLC2-Mediated Tumor Cell Stiffness
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411796 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xuanhe Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Ecology, Chinese Academy of Sciences, No. 72 Wenhua Road, Shenyang 110016, China. Hauptthemen laut MEDLINE: Enterotoxins, Antineoplastic Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation Project of Shenyang City, Livelihood Science and Technology Project of Liaoning Province, Zengcheng Entrepreneurship Leadership Team Project.
Abstract (Originalsprache)
As a biological macromolecule, the superantigen staphylococcal enterotoxin C2 (SEC2) is one of the most potent known T-cell activators, and it induces massive cytotoxic granule production. With this property, SEC2 and its mutants are widely regarded as immunomodulating agents for cancer therapy. In a previous study, we constructed an MHC-II-independent mutant of SEC2, named ST-4, which exhibits enhanced immunocyte stimulation and antitumor activity. However, tumor cells have different degrees of sensitivity to SEC2/ST-4. The mechanisms of immune resistance to SEs in cancer cells have not been investigated. Herein, we show that ST-4 could activate more powerful human lymphocyte granule-based cytotoxicity than SEC2. The results of RNA-seq and atomic force microscopy (AFM) analysis showed that, compared with SKOV3 cells, the softer ES-2 cells could escape from SEC2/ST-4-induced cytotoxic T-cell-mediated apoptosis by regulating cell softness through the CDC42/MLC2 pathway. Conversely, after enhancing the stiffness of cancer cells by a nonmuscle myosin-II-specific inhibitor, SEC2/ST-4 exhibited a significant antitumor effect against ES-2 cells by promoting perforin-dependent apoptosis and the S-phase arrest. Taken together, these data suggest that cell stiffness could be a key factor of resistance to SEs in ovarian cancer, and our findings may provide new insight for SE-based tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Applied Ecology, Chinese Academy of Sciences, No. 72 Wenhua Road, Shenyang 110016, China.
- Department of Immunology, Shenyang Medical College, No. 146 Huanghe North Street, Shenyang 110034, China.
- Key Laboratory of Superantigen Research of Liao Ning Province, Shenyang 110016, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Mingkai Xu
Förderung
- Natural Science Foundation Project of Shenyang City
- Livelihood Science and Technology Project of Liaoning Province
- Zengcheng Entrepreneurship Leadership Team Project
- Strategic Priority Research Program of the Chinese Academy of Sciences
Zitieren
APA
Fu, X., Xu, M., Yu, Z., Gu, W., Zhang, Z., Zhang, B., Wang, X., Su, Z., & Zhang, C. (2023). Staphylococcal Enterotoxin C2 Mutant-Induced Antitumor Immune Response Is Controlled by CDC42/MLC2-Mediated Tumor Cell Stiffness. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411796
Vancouver
Fu X, Xu M, Yu Z, Gu W, Zhang Z, Zhang B, et al. Staphylococcal Enterotoxin C2 Mutant-Induced Antitumor Immune Response Is Controlled by CDC42/MLC2-Mediated Tumor Cell Stiffness. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411796
BibTeX
@article{Fu2023,
author = {Fu, Xuanhe and Xu, Mingkai and Yu, Zhixiong and Gu, Wu and Zhang, Zhichun and Zhang, Bowen and Wang, Xiujuan and Su, Zhencheng and Zhang, Chenggang},
title = {Staphylococcal Enterotoxin C2 Mutant-Induced Antitumor Immune Response Is Controlled by CDC42/MLC2-Mediated Tumor Cell Stiffness},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411796}
}
EUVIMED